European Union - English - EMA (European Medicines Agency)

ab science s.a. - masitinib mesilate - antineoplastic agents - dogs - treatment of non-resectable dog mast-cell tumours (grade 2 or 3) with confirmed mutated c-kit tyrosine-kinase receptor.

European Union - English - EMA (European Medicines Agency)

ab science - masitinib mesilate - mastocytosis - antineoplastic agents - treatment of mastocytosis

European Union - English - EMA (European Medicines Agency)

ab science - masitinib mesilate - amyotrophic lateral sclerosis - antineoplastic agents - treatment of amyotrophic lateral sclerosis.

European Union - English - EMA (European Medicines Agency)

ab science - masitinib - pancreatic neoplasms - protein kinase inhibitors - treatment of non resectable locally advanced or metastatic pancreatic cancer

European Union - English - EMA (European Medicines Agency)

masitinib - gastrointestinal stromal tumors - l01xe - treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist),

European Union - English - EMA (European Medicines Agency)

masitinib - gastrointestinal stromal tumors - l01xe - treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist),

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ab science - masitinib - tablet - anti neoplastic agent - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ab science - masitinib - film-coated tablet - anti neoplastic agent - dogs